FDA Clearance Tracker · K221902
LimFlow Vector
Last checked: Nov 19, 2026Latest source record: Dec 21, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2022
Substantially Equivalent
Time to decision
174 days
Received Jun 30, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K221902
- Device name
- LimFlow Vector
- Applicant
- LimFlow, Inc.
- Applicant location
- San Jose, CA
- Received
- Jun 30, 2022
- Decided
- Dec 21, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Valvulotome (MGZ)
- Device class
- Class II
- Regulation
- 21 CFR 870.4885
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MGZ. The earliest in FDA's data is K911100, decided Jun 21, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K221902
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for LimFlow, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- LimFlow Vector510(k)
K260188 · Decided Mar 18, 2026 · 55 days after receipt
Device type: Valvulotome (MGZ) · Cardiology
- LimFlow ARC510(k)
K251376 · Decided May 31, 2025 · 29 days after receipt
Device type: Catheter For Crossing Total Occlusions (PDU) · Cardiology
- LimFlow V-Ceiver510(k)
K242776 · Decided Feb 14, 2025 · 154 days after receipt
Device type: Device, Percutaneous Retrieval (MMX) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.